Market cap
$2,101 Mln
Revenue (TTM)
$1,817 Mln
P/E Ratio
28.6
P/B Ratio
1.4
Div. Yield
0 %
| Colfax (CFX) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
2,101 | 12,753 | 12,153 | 10,906 | 9,948 |
Revenue ($ Mln) |
1,817 | 1,505 | 6,164 | 613 | 785 |
Net Profit ($ Mln) |
-81.91 | 160.59 | 625.00 | -188.05 | 41.54 |
Net Margin (%) |
-4.51 | 10.67 | 5.41 | -30.68 | 5.29 |
RoE (%) |
-2.43 | 10.86 | 11.84 | -28.10 | 1.97 |
Price to Earnings |
28.55 | 79.35 | 19.89 | -- | 251.81 |
Price-To-Book |
1.36 | 8.41 | 2.37 | 16.38 | 4.86 |
Income Statement ($ Mln)
| Colfax (CFX) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1,817.31 | 1,058.52 | 8,463.00 | 314.71 | 638.76 |
|
Cost of Revenue
|
763.70 | 375.88 | 2,511.00 | 75.58 | 354.52 |
|
Gross Profit
|
-- | 682.64 | 3,895.00 | 239.14 | 284.25 |
|
Operating Expenses
|
1,067.79 | 609.09 | 5,267.50 | 367.84 | 230.27 |
|
Operating Profit (EBIT)
|
-75.76 | 73.55 | 1,102.50 | -128.70 | 54.58 |
|
Other Income
|
0.00 | -2.33 | 0.00 | 2.38 | -4.37 |
|
Profit before Tax
|
-116.41 | 79.65 | 500.00 | -133.73 | 64.13 |
|
Provision for Tax
|
-30.15 | -11.30 | 76.50 | 0.93 | 22.56 |
|
Profit after Tax (Net Income)
|
-81.91 | 90.95 | 457.50 | -134.66 | 41.58 |
|
Minority Interest
|
0.00 | -- | 0.00 | -- | -- |
|
Consolidated Profit
|
0.00 | 90.95 | 0.00 | -99.20 | 185.96 |
Liabilities ($ Mln)
| Colfax (CFX) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
3,308.43 | 1,178.94 | 5,205.00 | 461.77 | 1,971.20 |
|
Minority Interest
|
0.00 | -- | 0.00 | -- | -- |
|
Non-Current Liabilities
|
1,618.71 | 226.22 | 3,560.00 | 404.63 | 695.05 |
|
Current Liabilities
|
549.13 | 151.14 | 1,777.00 | 74.01 | 158.16 |
|
Total Liabilities
|
4,509.33 | 1,556.31 | 9,987.00 | 940.41 | 2,824.41 |
Assets ($ Mln)
| Colfax (CFX) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
4,327.96 | 640.90 | 6,084.00 | 544.95 | 1,713.37 |
|
Current Assets
|
1,150.72 | 915.40 | 4,458.00 | 395.46 | 1,111.04 |
|
Total Assets
|
4,509.33 | 1,556.31 | 9,987.00 | 940.41 | 2,824.41 |
|
Total Debt*
|
1,412.93 | 234.34 | 3,655.00 | 383.74 | 711.80 |
|
Net Current Assets
|
0.00 | 764.26 | 2,681.00 | 321.45 | 952.88 |
Cashflow ($ Mln)
| Colfax (CFX) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-- | 97.33 | 608.00 | -57.76 | 113.92 |
|
Cash Flow from Investing Activities
|
-- | -16.08 | -448.00 | 14.10 | -233.24 |
|
Cash from Financing Activities
|
-- | 16.20 | -200.00 | 15.04 | 248.96 |
|
Net Cash Inflow / Outflow
|
-- | 10.75 | -- | 17.95 | -74.49 |
Ratios
Profitability Ratios
| Colfax (CFX) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-- | 6.87 | 3.20 | -15.32 | 1.66 |
|
ROE (%)
|
-2.43 | 8.35 | 8.78 | -27.16 | 2.14 |
|
ROA (%)
|
-1.39 | 6.21 | 3.82 | -13.37 | 1.55 |
|
EBIT Margin (%)
|
-5.99 | -- | 13.03 | -- | -- |
|
Net Margin (%)
|
-4.51 | 8.59 | 5.41 | -42.79 | 6.51 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Colfax (CFX) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
14.02 | 0.25 | 5.48 | 0.11 | -0.20 |
|
EBIT Growth (%)
|
-32.79 | -- | 5.30 | -- | -- |
|
Net Profit Growth (%)
|
-256.44 | 4,643.16 | 39.91 | -35.75 | -77.64 |
|
EPS Growth (%)
|
-242.86 | 45.98 | -13.71 | -0.33 | -0.77 |
|
Book Value Growth (%)
|
-4.55 | -- | -50.46 | -- | -- |
Valuation Ratios
| Colfax (CFX) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | 108.66 | 90.54 | -28.85 | 241.38 |
|
Price / Book Value
|
-- | 8.38 | 4.56 | 8.41 | 5.09 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | 90.46 | 21.91 | -48.39 | 80.42 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Colfax (CFX) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.20 | 0.60 | 0.83 | 0.36 |
|
Short term debt to equity ratio
|
0.01 | 0.01 | 0.07 | 0.00 | 0.04 |
|
Current Ratio
|
2.10 | 6.06 | 2.51 | 5.34 | 7.02 |
|
Quick Ratio
|
1.03 | 3.49 | 1.11 | 4.78 | 5.75 |
|
Interest Coverage
|
-2.41 | 46.80 | 4.16 | -8.81 | 5.61 |
Operating Efficiency Ratios
| Colfax (CFX) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
20.97 | 19.06 | 16.01 | 12.66 | 19.44 |
|
Asset Turnover
|
0.31 | 0.72 | 0.71 | 0.31 | 0.24 |
|
Receivable days
|
-- | 69.90 | 68.65 | 44.06 | 68.73 |
|
Inventory Days
|
-- | 350.81 | 507.91 | 192.90 | 226.97 |
|
Payable days
|
-- | 26.16 | 225.80 | 67.28 | 24.27 |
|
Cash Conversion Cycle
|
-- | 394.55 | 350.76 | 169.68 | 271.43 |